Houlihan Lokey, Inc. (NYSE:HLI) Position Boosted by Rheos Capital Works Inc.

Rheos Capital Works Inc. grew its holdings in shares of Houlihan Lokey, Inc. (NYSE:HLI) by 65.1% in the 3rd quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 63,400 shares of the financial services provider’s stock after purchasing an additional 25,000 shares during the period. Rheos Capital Works Inc.’s holdings in Houlihan Lokey were worth $10,018,000 as of its most recent filing with the Securities and Exchange Commission.

Several other large investors also recently made changes to their positions in HLI. Teachers Retirement System of The State of Kentucky bought a new position in shares of Houlihan Lokey during the 4th quarter valued at about $1,427,000. American International Group Inc. boosted its position in shares of Houlihan Lokey by 15,061.5% during the 4th quarter. American International Group Inc. now owns 69,743 shares of the financial services provider’s stock valued at $8,363,000 after purchasing an additional 69,283 shares in the last quarter. Vanguard Group Inc. boosted its position in shares of Houlihan Lokey by 2.9% during the 4th quarter. Vanguard Group Inc. now owns 5,074,300 shares of the financial services provider’s stock valued at $608,459,000 after purchasing an additional 143,560 shares in the last quarter. Quadrature Capital Ltd lifted its stake in Houlihan Lokey by 134.1% during the fourth quarter. Quadrature Capital Ltd now owns 11,636 shares of the financial services provider’s stock valued at $1,395,000 after buying an additional 6,665 shares in the last quarter. Finally, HighPoint Advisor Group LLC purchased a new stake in Houlihan Lokey during the fourth quarter valued at about $221,000. Institutional investors own 78.07% of the company’s stock.

Analyst Upgrades and Downgrades

A number of research firms have commented on HLI. Wells Fargo & Company began coverage on shares of Houlihan Lokey in a research note on Thursday, September 12th. They set an “underweight” rating and a $149.00 price objective for the company. Morgan Stanley upped their price objective on shares of Houlihan Lokey from $146.00 to $163.00 and gave the company an “equal weight” rating in a research note on Monday, September 23rd. UBS Group upped their price objective on shares of Houlihan Lokey from $170.00 to $190.00 and gave the company a “buy” rating in a research note on Tuesday, October 8th. Keefe, Bruyette & Woods reaffirmed a “market perform” rating and set a $154.00 price objective (up from $139.00) on shares of Houlihan Lokey in a research note on Wednesday, July 31st. Finally, JPMorgan Chase & Co. reduced their price objective on shares of Houlihan Lokey from $132.00 to $129.00 and set a “neutral” rating for the company in a research note on Wednesday, July 31st. One analyst has rated the stock with a sell rating, four have given a hold rating and one has issued a buy rating to the company’s stock. According to data from MarketBeat.com, the company presently has a consensus rating of “Hold” and a consensus target price of $157.00.

Insider Buying and Selling at Houlihan Lokey

In other Houlihan Lokey news, Chairman Scott L. Beiser sold 8,317 shares of the stock in a transaction that occurred on Friday, August 16th. The stock was sold at an average price of $151.89, for a total transaction of $1,263,269.13. The sale was disclosed in a filing with the SEC, which is accessible through the SEC website. In other news, Chairman Scott L. Beiser sold 8,317 shares of the firm’s stock in a transaction on Friday, August 16th. The shares were sold at an average price of $151.89, for a total value of $1,263,269.13. The sale was disclosed in a filing with the SEC, which is available at this hyperlink. Also, Director Gillian Beth Zucker sold 200 shares of the firm’s stock in a transaction on Friday, September 13th. The stock was sold at an average price of $152.28, for a total transaction of $30,456.00. Following the completion of the sale, the director now owns 6,801 shares in the company, valued at approximately $1,035,656.28. The trade was a 0.00 % decrease in their position. The disclosure for this sale can be found here. Insiders have sold a total of 9,917 shares of company stock worth $1,513,129 over the last 90 days. Insiders own 25.97% of the company’s stock.

Houlihan Lokey Price Performance

NYSE HLI opened at $171.50 on Thursday. The firm has a market capitalization of $11.76 billion, a price-to-earnings ratio of 41.73 and a beta of 0.66. The company has a 50 day simple moving average of $156.56 and a 200-day simple moving average of $142.24. Houlihan Lokey, Inc. has a 52-week low of $94.67 and a 52-week high of $172.31.

Houlihan Lokey (NYSE:HLI) last issued its quarterly earnings data on Tuesday, July 30th. The financial services provider reported $1.22 earnings per share for the quarter, meeting the consensus estimate of $1.22. Houlihan Lokey had a net margin of 15.30% and a return on equity of 18.80%. The firm had revenue of $514.00 million for the quarter, compared to analyst estimates of $508.70 million. During the same quarter last year, the firm earned $0.89 earnings per share. The company’s revenue for the quarter was up 23.6% on a year-over-year basis. On average, analysts predict that Houlihan Lokey, Inc. will post 5.64 EPS for the current year.

Houlihan Lokey Dividend Announcement

The business also recently declared a quarterly dividend, which was paid on Sunday, September 15th. Shareholders of record on Tuesday, September 3rd were issued a dividend of $0.57 per share. The ex-dividend date was Tuesday, September 3rd. This represents a $2.28 annualized dividend and a yield of 1.33%. Houlihan Lokey’s dividend payout ratio (DPR) is presently 55.47%.

About Houlihan Lokey

Houlihan Lokey, Inc, an investment banking company, provides merger and acquisition (M&A), capital market, financial restructuring, and financial and valuation advisory services worldwide. It operates in three segments: Corporate Finance, Financial Restructuring, and Financial and Valuation Advisory.